Tagrisso has been recommended as an adjuvant therapy following complete surgical resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor ...

Brain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...

Tagrisso has been recommended as an adjuvant therapy following complete surgical resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours have epidermal growth ...

Tagrisso has been recommended for use as an adjuvant treatment following complete resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours express epidermal growth ...

Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.

Alecensa (alectinib) is now an option for patients with stage 1b to 3a ALK-positive NSCLC who have ... In another positive development for the lung cancer community, NICE has also given its ...

Figure 3A illustrates the timelines of a 65-year-old LCS-eligible ... Patient's timelines with LCS or pack-years records. LCS, lung cancer screening; LDCT, low-dose computed tomography; PY, pack-year.

Greenwood Village resident Heidi Nafman-Onda personally knows the health risks. In 2018, she was diagnosed with stage 3A lung cancer and given a grave diagnosis. "The really scary thing about this was ...

Stage 2 Non-Small Cell Lung Cancer: Overview and More Understanding Stage 3A Non-Small Cell Lung Cancer Stage 3B Non-Small Cell Lung Cancer Treatments and Prognosis A high-energy radiation from X-rays ...